States Say $8.3B Purdue Opioid Deal Flouts Bankruptcy Rules
A group of states on Tuesday voiced opposition to Purdue Pharma LP's $8 billion OxyContin settlement with the federal government, saying that the plan puts the bankruptcy case parties in a...To view the full article, register now.
Already a subscriber? Click here to view full article